Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:DAWNNASDAQ:FLYW On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeDAWNDay One Biopharmaceuticals$6.80+1.0%$6.70$6.08▼$16.76$689.27M-1.271.15 million shs445,456 shsFLYWFlywire$11.83$10.81$8.20▼$23.40$1.44B1.281.90 million shs818,806 shsA Guide To High-Short-Interest StocksMarketBeat's analysts have just released their top five short plays for July 2025. Learn which stocks have the most short interest and how to trade them. Enter your email address to see which companies made the list.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceDAWNDay One Biopharmaceuticals0.00%+5.10%-2.16%-5.82%-49.63%FLYWFlywire0.00%+3.68%+16.21%+30.00%-25.92%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationDAWNDay One Biopharmaceuticals1.7176 of 5 stars3.62.00.00.00.02.50.0FLYWFlywire4.3159 of 5 stars4.15.00.00.02.02.51.9Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceDAWNDay One Biopharmaceuticals 3.13Buy$30.57349.58% UpsideFLYWFlywire 2.27Hold$15.0026.80% UpsideCurrent Analyst Ratings BreakdownLatest FLYW and DAWN Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails6/23/2025FLYWFlywireB. RileySubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetBuy ➝ Buy$17.00 ➝ $15.006/2/2025FLYWFlywireTruist FinancialSubscribe to MarketBeat All Access for the recommendation accuracy ratingInitiated CoverageBuy$12.005/8/2025FLYWFlywireThe Goldman Sachs GroupSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetNeutral ➝ Neutral$10.00 ➝ $12.005/7/2025DAWNDay One BiopharmaceuticalsWedbushSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingOutperform$25.005/7/2025DAWNDay One BiopharmaceuticalsNeedham & Company LLCSubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetBuy ➝ Buy$30.00 ➝ $27.005/7/2025FLYWFlywireRoyal Bank Of CanadaSubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetOutperform ➝ Outperform$20.00 ➝ $17.005/7/2025FLYWFlywireWells Fargo & CompanySubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetEqual Weight ➝ Equal Weight$16.00 ➝ $13.005/2/2025FLYWFlywireB. RileySubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingBuy ➝ Buy$29.00 ➝ $17.004/23/2025FLYWFlywireWolfe ResearchSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingOutperform ➝ Peer Perform4/14/2025FLYWFlywireJPMorgan Chase & Co.Subscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingNeutral ➝ Underweight$16.00 ➝ $9.00(Data available from 7/6/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookDAWNDay One Biopharmaceuticals$131.16M5.26N/AN/A$4.99 per share1.36FLYWFlywire$492.14M2.92$0.17 per share69.11$6.57 per share1.80Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateDAWNDay One Biopharmaceuticals-$95.50M-$0.71N/AN/AN/A-42.66%-14.98%-13.04%7/8/2025 (Estimated)FLYWFlywire$2.90M$0.04295.7547.321.690.97%1.57%1.15%8/5/2025 (Estimated)Latest FLYW and DAWN EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails7/29/2025Q2 2025DAWNDay One Biopharmaceuticals-$0.35N/AN/AN/A$35.55 millionN/A5/6/2025Q1 2025DAWNDay One Biopharmaceuticals-$0.46-$0.35+$0.11-$0.35$30.28 million$30.76 million5/6/2025Q1 2025FLYWFlywire$0.01$0.03+$0.02-$0.03$124.18 million$128.70 millionCompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthDAWNDay One BiopharmaceuticalsN/AN/AN/AN/AN/AFLYWFlywireN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioDAWNDay One BiopharmaceuticalsN/A10.6210.55FLYWFlywire0.082.022.02Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipDAWNDay One Biopharmaceuticals87.95%FLYWFlywire95.90%Insider OwnershipCompanyInsider OwnershipDAWNDay One Biopharmaceuticals6.20%FLYWFlywire4.40%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableDAWNDay One Biopharmaceuticals60101.36 million95.08 millionOptionableFLYWFlywire1,250121.56 million116.21 millionOptionableFLYW and DAWN HeadlinesRecent News About These CompaniesFlywire Corporation (NASDAQ:FLYW) Given Consensus Rating of "Hold" by BrokeragesJuly 5 at 2:37 AM | marketbeat.comVoss Capital’s New Long Addition: Flywire Corporation (FLYW)July 3 at 6:08 PM | msn.comJanney Montgomery Scott LLC Has $738,000 Stake in Flywire Corporation (NASDAQ:FLYW)July 2, 2025 | marketbeat.com3 Reasons to Sell FLYW and 1 Stock to Buy InsteadJuly 1, 2025 | msn.com5 Insightful Analyst Questions From Flywire’s Q1 Earnings CallJune 27, 2025 | msn.comB. Riley Comments on Flywire's Q2 Earnings (NASDAQ:FLYW)June 27, 2025 | americanbankingnews.comB. Riley Issues Pessimistic Forecast for Flywire EarningsJune 25, 2025 | marketbeat.comB. Riley Analysts Lift Earnings Estimates for FlywireJune 24, 2025 | marketbeat.comExpert Outlook: Flywire Through The Eyes Of 8 AnalystsJune 23, 2025 | benzinga.comB. Riley Cuts Flywire (NASDAQ:FLYW) Price Target to $15.00June 23, 2025 | marketbeat.comFlywire Corporation (FLYW) Slid on Lower Than Expected Revenue GuidanceJune 19, 2025 | insidermonkey.comFlywire Corporation (FLYW) Slid on Lower Than Expected Revenue GuidanceJune 19, 2025 | msn.comABS Direct Equity Fund LLC Makes New Investment in Flywire Co. (NASDAQ:FLYW)June 15, 2025 | marketbeat.comHarbor Capital Advisors Inc. Sells 184,898 Shares of Flywire Co. (NASDAQ:FLYW)June 15, 2025 | marketbeat.comProsper Stars & Stripes’ Short Thesis Bet on Flywire Corp. (FLYW) Paid OffJune 13, 2025 | msn.comFlywire (NASDAQ:FLYW) Trading Up 5.4% - Still a Buy?June 11, 2025 | marketbeat.comFlywire Co. (NASDAQ:FLYW) Director Edwin J. Santos Sells 5,000 SharesJune 10, 2025 | insidertrades.comFlywire Co. (NASDAQ:FLYW) Receives Consensus Recommendation of "Hold" from AnalystsJune 10, 2025 | marketbeat.comInsider Selling: Flywire Co. (NASDAQ:FLYW) Director Sells 5,000 Shares of StockJune 9, 2025 | marketbeat.comFlywire Co. (NASDAQ:FLYW) Director Sells $54,878.64 in StockJune 9, 2025 | marketbeat.com3 Cash-Heavy Stocks with Questionable FundamentalsJune 6, 2025 | finance.yahoo.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimeFLYW and DAWN Company DescriptionsDay One Biopharmaceuticals NASDAQ:DAWN$6.80 +0.07 (+1.04%) Closing price 07/3/2025 03:00 PM EasternExtended Trading$6.80 0.00 (0.00%) As of 07/3/2025 04:20 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Day One Biopharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops and commercializes targeted therapies for patients with genomically defined cancers. Its lead product candidate is tovorafenib, an oral brain-penetrant type II pan-rapidly accelerated fibrosarcoma kinase inhibitor that is in Phase II clinical trial for pediatric patients with relapsed/ refractory low-grade glioma. The company is also developing Pimasertib, an oral small molecule inhibitor of mitogen-activated protein kinase kinases 1 and 2. Day One Biopharmaceuticals, Inc. was incorporated in 2018 and is headquartered in Brisbane, California.Flywire NASDAQ:FLYW$11.83 0.00 (0.00%) Closing price 07/3/2025 03:11 PM EasternExtended Trading$11.83 0.00 (0.00%) As of 07/3/2025 04:33 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Flywire Corporation, together with its subsidiaries, operates as a payments enablement and software company in the United States and internationally. Its payment platform and network, and vertical-specific software help clients to get paid and help their customers to pay. The company's platform facilitates payment flows across multiple currencies, payment types, and payment options, as well as provides direct connections to alternative payment methods, such as Alipay, Boleto, PayPal/Venmo, and Trustly. It serves education, healthcare, travel, and business to business organizations. The company was formerly known as peerTransfer Corporation and changed its name to Flywire Corporation in December 2016. Flywire Corporation was incorporated in 2009 and is headquartered in Boston, Massachusetts. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30EcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas MarketBeat Week in Review – 06/30 - 07/04 The Apple Comeback Will Be Better Than the Setback Micron’s Big Q3 Drives Applied Materials’ Bullish Outlook Correction Equals Opportunity in Domino’s Pizza Stock Why Occidental's Price Dip Signals a Buying Opportunity Qualcomm’s Hold Rating Misses Strong Growth Story Rigetti Computing: Cantor's Bullish Call May Be Just the Start Insider Selling at NVIDIA Could Turn Into an Opportunity Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
